View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 27, 2022updated 04 Feb 2022 10:35am

Distalmotion closes financing to fast-track surgical robots’ adoption

Dexter combines the benefits of robotics and affordability of laparoscopy to create a novel approach to robotic surgery.

Medical equipment manufacturer Distalmotion has raised $90m in a funding round led by Revival Healthcare Capital to accelerate the commercialisation of its surgical robot, Dexter, across the world.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

In addition to existing investors, venture capital firm 415 Capital participated in the round.

Dexter combines the benefits of robotics and affordability of laparoscopy to create a novel approach to robotic surgery.

The product returns surgeons to the sterile field, providing direct access to patients while integrating laparoscopic workflows into the robotic setup.

It was developed with a focus on making the surgeon the central point of procedures and the aim of adding a simple and versatile setup to the market that would reduce complexity.

Distalmotion CEO Michael Friedrich said: “By addressing essential problems that operating room teams face, we can deliver on our mission to fast-track widespread adoption of robotic surgery in minimally invasive care.”

The company noted that the latest funding comes after the completion of its first clinical cases and will help it accelerate the commercial scaling of Dexter.

It also noted that procedural guidelines and training protocols for robotic surgery are being developed in leading hospitals across Europe due to the involvement of Dexter in an Early Adopter Program (EAP) and clinical studies.

With the investment support, Distalmotion will work with the US Food and Drug Administration (FDA) regarding a US submission.

Distalmotion incoming chairman and Revival chairman Rick Anderson said: “The market is overdue for a fundamentally new approach to robotic surgery, where the mindset needs to be about ‘the surgeon’s robot,’ not moulding ‘the robot’s surgeon’.

“Dexter is designed to work the way surgeons and operating room (OR) teams work: patient-focused and user-centric, providing necessary patient access and optimal tools for every step of the way.”

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network